China Seeks Plasma From Recovered Patients as Virus Treatment
- Local drugmaker says plasma from cured patients has antibodies
- Company claims this line of treatment is the “most effective”
This article is for subscribers only.
China’s state-owned medical products maker is collecting plasma from the blood of people who have recovered from the novel coronavirus after discovering it helped critically ill patients.
China National Biotec Group Co. has been using this plasma, which contains highly potent antibodies, to treat more than 10 seriously ill patients since Feb. 8, the company said in an statement on its official WeChat account Thursday night. It claimed that those receiving the treatment improved within 24 hours, with reduced inflammation and viral loads along with better oxygen levels in the blood.